Sen. Hernandez Pulls Bill On Drug Price Transparency
(By Ana B. Ibarra for California Healthline) After being approved by a key committee last week, a bill that would
Read More
Part D/Prescription Drugs
Scientists Engineer An Opioid That May Reduce Pain With Less Risk
(By Angus Chen for NPR) Once people realized that opioid drugs could cause addiction and deadly overdoses, they tried to
Read MoreUK patient groups urge government to negotiate drug prices
(By Ed Silverman for ST A T) A rguing that cancer patients in the United Kingdom are missing out on
Read MoreJudge denies petition by supporters of California drug pricing ballot
(By Ed Silverman for ST A T) S upporters of a California ballot measure, which is designed to lower drug
Read MoreLaws to shed light on drug pricing strategies probably won’t work
(By Ed Silverman for ST A T) F rom coast to coast, state lawmakers are pushing legislation in hopes of
Read MoreStudy Says FluMist Vaccine Does Indeed Work, Contradicting CDC
(By Tara Haelle for NPR) It came as a surprise this June when the Centers for Disease Control and Prevention
Read MoreBiosimilar names may affect pharmacist dispensing habits
(By Ed Silverman for ST A T) W hat’s in a name? An awful lot when it comes to biosimilars.
Read MoreMolecular origami: Protein engineering emerges to fight disease
(By Anna Vlasits for ST A T) S EATTLE — Protein engineer Aaron Chevalier has a hunch that origami —
Read MoreWill Your Prescription Meds Be Covered Next Year? Better Check!
(By Alison Kodjak for NPR) The battle continues to rage between drug companies that are trying to make as much
Read MoreClinton and Trump are both wrong about Medicare’s ability to negotiate drug prices
(By Geoffrey F. Joyce and Neeraj Sood for ST A T) Hillary Clinton and Donald Trump agree that Medicare bureaucrats
Read More